✦ LIBER ✦

Corticosteroid therapy for chronic active hepatitis B: Is a little too much?

✍ Scribed by Robert P. Perrillo; Fredric G. Regenstein

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 350 KB
Volume: 6
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840060633

No coin nor oath required. For personal study only.

✦ Synopsis

Long-term corticosteroid therapy for chronic active hepatitis B has been reported to be deleterious (1, 2),

📜 SIMILAR VOLUMES

Long-term lamivudine therapy for childre

Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B

✍ Etienne M. Sokal; Deirdre A. Kelly; Jacek Mizerski; Isabel B. Badia; Jorge A. Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

One year of lamivudine treatment results in increased hepatitis B e antigen (HBeAg) seroconversion and serum hepatitis B virus (HBV) DNA negativity in children with chronic hepatitis B and high serum alanine aminotransferase concentrations. Two hundred seventy-six children who participated in a 1-ye

Combined Interferon and Lamivudine Thera

Combined Interferon and Lamivudine Therapy: Is This The Treatment of Choice for Patients With Chronic Hepatitis B Virus Infection?

✍ Norah A. Terrault 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views